The Effects of Labor Stages and Interventions on Hemodynamic Measures During & After Childbirth With Noninvasive Sensors

Not Applicable

Completed

• Conditions: Rupture of Membranes; Premature; Preeclampsia; Cesarean Section; Infection
• Interventions: Device: biobeat sensor

• Registration Number: NCT03838965
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

The Effects of Labor Stages and Interventions on Hemodynamic Measures During and After Childbirth ( Epidural, Rupture Membranses Cesarean Sections and Preeclampsia) With Noninvasive Sensors.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-01-30
• Study First Submitted QC: 2019-02-11
• Study First Posted: 2019-02-12
• Study Start: 2019-03-01
• Primary Completion: 2020-12-16
• Study Completion: 2020-12-16
• Status Verified: 2022-06
• Last Update Submitted: 2022-06-22
• Last Update Posted: 2022-06-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

• Pregnant woman between 18-45 years old
• with non cardiovascular disease

Exclusion Criteria

• woman with a cardiovascular disease
• woman who don't agree to participate in the trial

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
biobeat sensor	biobeat sensor	-

Primary Outcome Measures

Name	Time	Method
biobeat sensor is a noninvasive sensor of the the hymodynamic measures during the childbirth	24 hours	biobeat sensor is a noninvasive sensor of the the hymodynamic measures during the childbirth

Secondary Outcome Measures

Name	Time	Method
biobeat sensor is a noninvasive sensor of the the hymodynamic measures after 24 hours of the childbirth	24 hours	biobeat sensor is a noninvasive sensor of the the hymodynamic measures after 24 hours of the childbirth

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel